Cancer and Metastasis Reviews

Gastroenteropancreatic neuroendocrine tumors. Where are we now?
pp. 1-1(1)
Author: Castellano, Daniel

Current knowledge on diagnosis and staging of neuroendocrine tumors
pp. 3-7(5)
Authors: Öberg, Kjell; Castellano, Daniel

Somatostatin analogs for the treatment of neuroendocrine tumors
pp. 9-17(9)
Authors: Culler, Michael; Öberg, Kjell; Arnold, Rudolf; Krenning, Eric; Sevilla, Isabel; Díaz, José

Therapy innovations: tyrosine kinase inhibitors for the treatment of pancreatic neuroendocrine tumors
pp. 19-26(8)
Authors: Raymond, Eric; Hobday, Timothy; Castellano, Daniel; Reidy-Lagunes, Diane; García-Carbonero, Rocío; Carrato, Alfredo

Innovations therapy: mammalian target of rapamycin (mTOR) inhibitors for the treatment of neuroendocrine tumors
pp. 27-34(8)
Authors: Capdevila, Jaume; Salazar, Ramón; Halperín, Irene; Abad, Albert; Yao, James

Future perspectives on neuroendocrine tumors
pp. 35-40(6)
Authors: Castellano, Daniel; Salazar, Ramón; Raymond, Eric